Dow Jones Industrial Average Struggles as Trump Sinks Drug Stocks

The Biotech Bucking the Sector Sell-Off

Mar 7, 2017 at 12:10 PM
facebook twitter linkedin

After a short trek into positive territory, the Dow Jones Industrial Average (DJIA) is trading back below breakeven. Stocks are reacting to a broad sell-off in the healthcare sector, after House Republicans introduced their Obamacare replacement plan, and President Donald Trump took to Twitter to weigh in on drug prices. While the Dow fights to avoid its first back-to-back loss since late January, the Nasdaq Composite (COMP) and the S&P 500 Index (SPX) are also in the red.  

Continue reading for more on today's market -- and don't miss:

  • The social media stock up 12% after earnings. 
  • 2 reasons to trade TASER International, Inc. (NASDAQ:TASR) call options
  • Plus, Texas Instruments explodes, the biotech that's tripled since December, and Dick's suffers post-earnings.

stock market news today march 7

Texas Instruments Incorporated (NASDAQ:TXN) is storming up the charts, hitting another 16-year high of $80.37, last seen 1.9% higher at $79.76. In the options pits, volume is extremely accelerated -- with 26,000 contracts on the tape, eight times the average intraday pace -- thanks to two symmetrical 10,000-contract blocks of April 77.50 calls and puts that were simultaneously initiated earlier. While it's not clear at the moment, it's possible one trader opened either a synthetic long or a long straddle in the back-month series.

Despite the sector headwinds, biotech Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) is again making a big move on the Nasdaq, last seen 16.4% higher at $6.24, as Wall Street continues to dissect the company's Lupus treatment results from late last week. The shares earlier hit a five-year high of $6.55, and have now more than tripled in value since their December low. 

AUPH stock chart march 7

Over on the Big Board, Dick's Sporting Goods Inc (NYSE:DKS) is falling, after the company delivered a weaker-than-expected current-quarter forecast. The stock was last seen 8.7% lower at $48.02, and short sellers have to be cheering. DKS shares have shed 23% since their December peak at $62.80.

Don't miss the stock market's big finish. Sign up now for Schaeffer's Market Recap.


Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

Schaeffer's Daily Bulletin Offer


Special Offers from Schaeffer's Trading Partners